“Most of the vaccinated individuals were between 20 and 59 years old, and France was the country where the highest number of doses were administered,” the researchers explained, specifying that the vaccines came from Pfizer, Moderna, and AstraZeneca.
These results did not reassure health professionals — much less the patients.
Researchers observed an increase in cases of Guillain-Barré syndrome and cerebral venous thrombosis after the administration of the first dose of the AstraZeneca vaccine.
Guillain-Barré syndrome is mainly characterized by muscle weakness, while venous thrombosis involves the formation of a blood clot in a vein, obstructing circulation to the rest of the body.
French basketball player Victor Wembanyama suffered from this condition a few months ago, which forced him to end his season.
More research is needed (10/10)
Continue reading…
